Obesity

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings …

Obesity is no longer a looming crisis – it’s a present and escalating public health emergency across Europe. More than half of EU adults are now overweight, and nearly one …

According to reports, the US could deny a visa to applicants with certain health issues, which include diabetes, heart disease, and …

The United States has introduced new guidance that could see foreign nationals denied visas or green cards on the basis of pre-existing chronic health conditions, including diabetes, obesity, and heart …

November 05, 2025 4 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email …

Innovent Biologics, Inc.’s investigative GLP-1/glucagon (GCG) dual receptor agonist mazdutide has met its primary endpoint of superiority to semaglutide in HbA1c and body weight reduction in patients with type 2 …

Want to watch Dr. Mark Cucuzella’s full talk and hear from more experts about transforming healthcare? To unlock access to all …

MM device used to deliver low-dose PEMF. The device measures 50 cm (W) × 60 cm (L) × 110 cm (H), with a treatment chamber with an internal diameter of …

Diagnoses of diabetes have reached an all-time high despite a “statistically meaningful decrease” in the U.S. adult obesity rate, Gallup reported. The diabetes rate is now at 13.8 percent, the …

artificial intelligence (ai) It offers predictive analytics to transform dietary management for diabetes and obesity, personalized nutritional planning, real-time glucose monitoring, and improve patient outcomes.AI-driven tools analyse dietary habits, metabolic …